James Hsin Chung Yao from 13117 5Th St, Yukon, OK 73099, age 57, Phone: 4052650630

Medicine Doctors

Dr. James H Yao, Travis AFB CA - DMD (Doctor of Dental Medicine)

view source

Specialties:

Endodontics

Address:

101 Bodin Cir, Travis Afb, CA 94535
7074237083 (Phone)

Languages:

English

James C. Yao

view source

Specialties:

Medical Oncology

Education:

Medical School
Baylor College of Medicine
Graduated: 1995

Procedures:

Chemotherapy

Conditions:

Gastric Cancer
Malignant Neoplasm of Esophagus
Pancreatic Cancer
Rectal, Abdomen, Small Intestines, or Colon Cancer

Description:

Dr. Yao graduated from the Baylor College of Medicine in 1995. He works in Houston, TX and specializes in Medical Oncology. Dr. Yao is affiliated with Memorial Hermann Texas Medical Center and University Of Texas MD Anderson Cancer Center.

Name / Title

Company / Classification

Phones & Addresses

James Yao
President

Pacific Marine & Trading Company, Inc

Resumes

James Yao

view source

Work:

Nitto Denko
Rf Design Engineer

James Yao

view source

Skills:

Key Account
Www
Mold

James Yao

view source

James Yao

view source

James Yao

view source

James Yao

view source

Location:

United States

James Yao

view source

License Records

James C Yao

License #:

070094-21 - Expired

Category:

Nursing

Type:

Registered Nurse

James C Yao

License #:

070094-21 - Expired

Category:

Nursing

Type:

Registered Nurse

James H Yao

Address:

Yukon, OK 73099

License #:

DS030471L - Active

Category:

Dentistry

Type:

Dentist

Isbn (Books And Publications)

Aortic Surgery

view source

Author
James Yao

ISBN #
0721629148

News

Two Oral Cancer Drugs Effective in 'Steve Jobs' Disease

view source

Patients taking sunitinib survived disease-free for a median of 11.4 months, compared with 5.5 months for those on placebo, according to Eric Raymond, MD, PhD, of Hopital Beaujon in Clichy, France, and colleagues, while those on everolimus had a median progression-free survival of 11 months compared with 4.6 months for placebo patients, according to James Yao, MD, of MD Anderson Cancer Center in Houston (P
Date: Feb 09, 2011
Category: Health
Source: Google

2 Experimental Drugs Show Promise for Rare Pancreatic Cancer

view source

SOURCES: James Yao, M.D., associate professor and deputy chair, gastrointestinal medical oncology, University of Texas M.D. Anderson Cancer Center, Houston; Bhoomi Mehrotra, M.D., section head, medical oncology and stem cell transplantation program, North Shore-Long Island Jewish Medical Center, New Hyde Park, N.Y.; Feb. 10, 2011, New England Journal of Medicine
Date: Feb 09, 2011
Category: Health
Source: Google

2 Experimental Drugs Show Promise for Rare Pancreatic Cancer

view source

"I had a pretty good feeling about the study," said Dr. James Yao, lead author of the everolimus research and deputy chair of gastrointestinal medical oncology at the University of Texas M.D. Anderson Cancer Center. "This is certainly what we were hoping for. I think the magnitude of the treatment difference was very good to us."
Date: Feb 09, 2011
Category: Health
Source: Google